Kazuki YoshidaArtificial intelligence in #pharmacovigilance: A regulatory perspective on explainability - Pinheiro - 2022 - #Pharmacoepidemiology and Drug Safety - Wiley Online Library
https://onlinelibrary.wiley.com/doi/full/10.1002/pds.5524?campaign=woletoc
An overview of propensity score matching methods for clustered data - Benjamin Langworthy, Yujie Wu, Molin Wang, 2022
https://journals.sagepub.com/doi/abs/10.1177/09622802221133556 #Pharmacoepidemiology #biostatistics
A latent class model to multiply impute missing treatment indicators in observational studies when inferences of the treatment effect are made using propensity score matching - Mitra - Biometrical Journal - Wiley Online Library
https://onlinelibrary.wiley.com/doi/full/10.1002/bimj.202100284?campaign=wolearlyview #pharmacoepidemiology #biostatistics
OfflineIf you’re interested in what I do: Join #Sentinel Initiative Principal Investigator @[email protected] and members of the #USFDA at 3:40PM EST today for the Sentinel System Operations and Coordinating Center Perspectives session during the Annual Sentinel Initiative Workshop. #PublicHealth #Pharmacoepidemiology http://tinyurl.com/sentinelpublicmeeting
Hello #rheumatology #pharmacoepidemiology #epidemiology #biostatistics communities
#introduction I am a rheumatologist by clinical training, pharmacoepidemiologist by academic training. I work at a health care data/analytics company as a medical director and am involved in data product development and research projects in rheumatology/immunology.
#introduction I am a rheumatologist by clinical training, pharmacoepidemiologist by academic training. I work at a health care data/analytics company as a medical director and am involved in data product development and research projects in rheumatology/immunology.
Hello mastodon #Pharmacoepidemiology !